Discover our medicines
Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
Explore our science
Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
Learn about our impact
Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.
Novartis Financial Results – Q2 2025
Novartis announces the company’s financial results for the second quarter and first half of 2025.
Latest news
Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the company
Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
Novartis receives approval for first malaria medicine for newborn babies and young infants
Live. Magazine
Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company.
Novartis in Society Integrated Report 2024
Read more about our performance against our business, environmental, social and governance (ESG) priorities in the Novartis in Society Integrated Report 2024.